Original Research

Published on 08 Sep 2022

Network Pharmacology and Bioinformatics Analysis Identifies Potential Therapeutic Targets of Paxlovid Against LUAD/COVID-19

in Cancer Endocrinology

Wentao Zhang
Zhe Yang
Fengge Zhou
Yanjun Wei
Xiaoqing Ma

Frontiers in Endocrinology

doi 10.3389/fendo.2022.935906

9,148 views
5 citations

Review

Published on 08 Sep 2022

Towards an era of precise diagnosis and treatment: Role of novel molecular modification-based imaging and therapy for dedifferentiated thyroid cancer

in Cancer Endocrinology

Jing Li
Yingjie Zhang
Fenghao Sun
Ligang Xing
Xiaorong Sun

Frontiers in Endocrinology

doi 10.3389/fendo.2022.980582

5,767 views
1 citation

Original Research

Published on 06 Sep 2022

Importins involved in the nuclear transportation of steroid hormone receptors: In silico and in vitro data

in Cancer Endocrinology

Konstantina Kalyvianaki
Athanasios A. Panagiotopoulos
Maria Patentalaki
Elias Castanas
Marilena Kampa

Frontiers in Endocrinology

doi 10.3389/fendo.2022.954629

2,563 views
2 citations

Original Research

Published on 06 Sep 2022

Comparison of dyslipidemia incidence in Chinese early-stage breast cancer patients following different endocrine therapies: A population-based cohort study

in Cancer Endocrinology

Junren Wang
Jin Yin
Jiajun Qiu
Jingwen Jiang
Yao Hu
Kunrui Zhu
Hong Zheng
Ting Luo
Xiaorong Zhong

Frontiers in Endocrinology

doi 10.3389/fendo.2022.815960

2,603 views
4 citations

Original Research

Published on 05 Sep 2022

Renal oncometabolite L-2-hydroxyglutarate imposes a block in kidney tubulogenesis: Evidence for an epigenetic basis for the L-2HG-induced impairment of differentiation

in Cancer Endocrinology

Mary Taub
Nader H. Mahmoudzadeh
Jason M. Tennessen
Sunil Sudarshan

Frontiers in Endocrinology

doi 10.3389/fendo.2022.932286

2,667 views
9 citations

Original Research

Published on 02 Sep 2022

Identifying key genes of classic papillary thyroid cancer in women aged more than 55 years old using bioinformatics analysis

in Cancer Endocrinology

Chang-Chun Li
Muhammad Hasnain Ehsan Ullah
Xiao Lin
Su-Kang Shan
Bei Guo
Ming-Hui Zheng
Yi Wang
Fuxingzi Li
Ling-Qing Yuan

Frontiers in Endocrinology

doi 10.3389/fendo.2022.948285

3,857 views
2 citations

Original Research

Published on 31 Aug 2022

Identification of a novel histone phosphorylation prognostic signature in hepatocellular carcinoma based on bulk and single-cell RNA sequencing

in Cancer Endocrinology

Lei Fan
Ling Xu
Shan Tian
Xin Zheng

Frontiers in Endocrinology

doi 10.3389/fendo.2022.965445

5,270 views
3 citations

Review

Published on 30 Aug 2022

Androgen receptor in breast cancer: The “5W” questions

in Cancer Endocrinology

Sara Ravaioli
Roberta Maltoni
Barbara Pasculli
Paola Parrella
Anna Maria Giudetti
Daniele Vergara
Maria Maddalena Tumedei
Francesca Pirini
Sara Bravaccini

Frontiers in Endocrinology

doi 10.3389/fendo.2022.977331

7,209 views
15 citations

Original Research

Published on 30 Aug 2022

Nomogram models for stratified prediction of axillary lymph node metastasis in breast cancer patients (cN0)

in Cancer Endocrinology

Xin Gao
Wenpei Luo
Lingyun He
Lu Yang

Frontiers in Endocrinology

doi 10.3389/fendo.2022.967062

3,827 views
16 citations

Original Research

Published on 30 Aug 2022

Prognostic model based on m6A-associated lncRNAs in esophageal cancer

in Cancer Endocrinology

Weidong Wang
Danhong Dong
Pengfei Yu
Tong Chen
Ruiqi Gao
Jiangpeng Wei
Zhenchang Mo
Haikun Zhou
Qinchuan Yang
Chao Yue

Frontiers in Endocrinology

doi 10.3389/fendo.2022.947708

3,805 views
5 citations

Original Research

Published on 29 Aug 2022

What’s the difference between lung adenocarcinoma and lung squamous cell carcinoma? Evidence from a retrospective analysis in a cohort of Chinese patients

in Cancer Endocrinology

Wen Wang
Hui Liu
Guoli Li

Frontiers in Endocrinology

doi 10.3389/fendo.2022.947443

13,472 views
14 citations

Original Research

Published on 29 Aug 2022

Classification of pyroptosis patterns and construction of a novel prognostic model for prostate cancer based on bulk and single-cell RNA sequencing

in Cancer Endocrinology

Jianhan Fu
Guoqiang Li
Ruixiang Luo
Zhijie Lu
Yinhuai Wang

Frontiers in Endocrinology

doi 10.3389/fendo.2022.1003594

4,032 views
7 citations

Original Research

Published on 29 Aug 2022

Sphingolipid metabolism is associated with osteosarcoma metastasis and prognosis: Evidence from interaction analysis

in Cancer Endocrinology

Xinyue Hu
Xin Zhou
Jue Zhang
Liangliang Li

Frontiers in Endocrinology

doi 10.3389/fendo.2022.983606

3,076 views
4 citations

Review

Published on 25 Aug 2022

Biological effects and regulation of IGFBP5 in breast cancer

in Cancer Endocrinology

Jürgen Dittmer

Frontiers in Endocrinology

doi 10.3389/fendo.2022.983793

4,925 views
16 citations

Review

Published on 25 Aug 2022

The tumor microenvironment of hepatocellular carcinoma and its targeting strategy by CAR-T cell immunotherapy

in Cancer Endocrinology

Zhang Guizhen
Ji Guanchang
Liu Liwen
Wang Huifen
Ren Zhigang
Sun Ranran
Yu Zujiang

Frontiers in Endocrinology

doi 10.3389/fendo.2022.918869

7,146 views
19 citations

Editorial

Published on 24 Aug 2022

Editorial: New strategies in treatment of differentiated thyroid carcinoma

in Cancer Endocrinology

Jose Federico Carrillo
Carlos Suarez
Alvaro Sanabria
T Metin Onerci
Dhairyasheel Savant

Frontiers in Endocrinology

doi 10.3389/fendo.2022.1004734

1,973 views

Navigation group

Articles

Network Pharmacology and Bioinformatics Analysis Identifies Potential Therapeutic Targets of Paxlovid Against LUAD/COVID-19

Towards an era of precise diagnosis and treatment: Role of novel molecular modification-based imaging and therapy for dedifferentiated thyroid cancer

Importins involved in the nuclear transportation of steroid hormone receptors: In silico and in vitro data

Comparison of dyslipidemia incidence in Chinese early-stage breast cancer patients following different endocrine therapies: A population-based cohort study

Renal oncometabolite L-2-hydroxyglutarate imposes a block in kidney tubulogenesis: Evidence for an epigenetic basis for the L-2HG-induced impairment of differentiation

Identifying key genes of classic papillary thyroid cancer in women aged more than 55 years old using bioinformatics analysis

Identification of a novel histone phosphorylation prognostic signature in hepatocellular carcinoma based on bulk and single-cell RNA sequencing

Androgen receptor in breast cancer: The “5W” questions

Nomogram models for stratified prediction of axillary lymph node metastasis in breast cancer patients (cN0)

Prognostic model based on m6A-associated lncRNAs in esophageal cancer

What’s the difference between lung adenocarcinoma and lung squamous cell carcinoma? Evidence from a retrospective analysis in a cohort of Chinese patients

Classification of pyroptosis patterns and construction of a novel prognostic model for prostate cancer based on bulk and single-cell RNA sequencing

Sphingolipid metabolism is associated with osteosarcoma metastasis and prognosis: Evidence from interaction analysis

Biological effects and regulation of IGFBP5 in breast cancer

The tumor microenvironment of hepatocellular carcinoma and its targeting strategy by CAR-T cell immunotherapy

Editorial: New strategies in treatment of differentiated thyroid carcinoma